Browse Category

Stock Market News 28 January 2026

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Gilead Sciences shares rose 2.3% to $140.97 Tuesday, hitting a 52-week high after Medicare named its HIV drug Biktarvy for price negotiations starting in 2028. Trading volume topped 10.5 million shares. CEO Daniel O’Day sold 115,640 shares last week under a pre-set plan. Gilead will report fourth-quarter and full-year results after markets close on Feb. 10.
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase shares fell 1.2% to $210.83 in after-hours trading Tuesday, despite Cantor Fitzgerald starting coverage with an Overweight rating and a $277 price target. Britain’s ad regulator banned a Coinbase campaign, saying it downplayed crypto risks; Coinbase disputed the ruling. Bitcoin rose 0.7% to $89,313, while Ether gained 2.6%. Coinbase’s next earnings report is pending.
28 January 2026
Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab shares rose 8% Tuesday before slipping after hours, following a recent Neutron Stage 1 tank rupture that cast uncertainty on the rocket’s launch timeline. The stock traded near $87, up from $80.48, after rebounding from a 9.5% drop Monday. Investors await the late-February earnings call for updates on the Neutron program. The company also secured an $816 million U.S. defense contract.
Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana shares closed up 0.9% at $477.75 after volatile trading Tuesday. Wells Fargo raised its price target to $525, citing strong retail trends but flagged possible weather-related risks. Options trading showed a surge in put buying ahead of the Fed decision and Carvana’s Feb. 18 earnings. Implied volatility remained high, with puts outnumbering calls by nearly two to one.
28 January 2026
Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy closed up 1.2% at $288.76 Tuesday, after trading between $282.50 and $290.40. PJM Interconnection advanced a fast-track plan for data-center hookups and began talks on a government-backed “backstop” auction for new power capacity. Traders are watching natural-gas volatility and PJM/FERC policy moves. Constellation’s next earnings update is expected Feb. 17.
28 January 2026
Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health shares fell 14.3% to $322.92 Tuesday after a Medicare Advantage rate proposal from CMS projected a net average payment increase of just 0.09%, far below Wall Street expectations. The move triggered a broader selloff in health insurer stocks. Investors are awaiting Elevance’s earnings report Wednesday for updates on pricing and costs. CMS will finalize policy milestones in late February and early April.
Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies shares dropped 9.7% to $369.27 in after-hours trading Tuesday after the company issued a 2026 profit and revenue forecast below Wall Street estimates and warned of continued weak demand at its Deltek unit. Stifel downgraded the stock, citing ongoing Deltek softness. Roper reported Q4 revenue up 10% to $2.06 billion and adjusted EPS of $5.21. The company projected 2026 adjusted EPS of $21.30–$21.55.
28 January 2026
Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson shares rose 1.3% Tuesday after the FDA approved a Darzalex Faspro combination for newly diagnosed multiple myeloma patients ineligible for stem-cell transplants. The S&P 500 closed at a record high, while healthcare stocks broadly fell after a Medicare payment proposal. The U.S. also named 15 drugs for future Medicare price negotiations, increasing pressure on big pharma.
KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA shares rose 4.8% to about $1,616 in after-hours trading Tuesday after Evercore ISI and Wolfe Research raised price targets ahead of Thursday’s earnings. The company projects fiscal Q2 revenue of $3.225 billion and non-GAAP EPS of $8.70, with Zacks’ consensus slightly higher. KLA warned U.S.-China trade tensions could cut sales by up to $350 million over the next five quarters.

Stock Market Today

Shell share price in focus after Kazakhstan investment pause and PwC audit switch

Shell share price in focus after Kazakhstan investment pause and PwC audit switch

8 February 2026
Shell will pause new investments in Kazakhstan amid ongoing legal disputes over $16.5 billion in contested costs at major oilfields, CEO Wael Sawan said. Shell shares closed at 2,774.5 pence on Friday. The company repurchased 1.64 million shares on Feb. 6 as part of its ongoing buyback. Shell named PwC as auditor from 2027, replacing EY, which is under investigation by UK regulators.
RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

RELX share price slides again on AI worries; what to watch ahead of Feb 12 results

8 February 2026
RELX shares fell 4.6% to 2,145p on Friday, near a 52-week low, despite the FTSE 100 closing higher. The company disclosed a new buyback of 465,361 shares on Feb. 6 and has repurchased over 8.8 million shares since Jan. 2. Investors await RELX’s full-year 2025 results on Feb. 12 amid concerns over AI’s impact on its core business.
Glencore shares steady after Rio walks away — what to watch before Monday’s trade

Glencore shares steady after Rio walks away — what to watch before Monday’s trade

8 February 2026
Glencore shares closed up 0.6% at 478.10 pence Friday after Rio Tinto ended merger talks, issuing a “no intention to bid” statement. Glencore’s board rejected the proposed deal terms, citing concerns over valuation and governance. Attention now turns to possible asset sales, including its $5 billion Kazzinc stake, ahead of Glencore’s annual results on Feb. 18.
Go toTop